-- 独立系調査会社CFRAは、に対し、以下の調査レポートを提供しました。CFRAのアナリストは、以下のように見解をまとめています。ZTSは、2026年第1四半期に厳しい業績を記録しました。調整後EPSは1.53ドル（前年同期比9%増）で、市場予想の1.62ドルを下回りましたが、売上高は22億6,200万ドル（前年同期比3%増）で、市場予想通りでした。業績は地域ごとの動向の違いを反映しており、国際部門は前年同期比17%増（11億4,900万ドル）と好調だった一方、米国部門は8%減（10億9,000万ドル）となりました。同社は、主要な皮膚科分野における競争激化と、米国ペットオーナーに影響を与えるマクロ経済の逆風に直面し、動物病院への受診回数の減少とプレミアム製品への需要低迷につながりました。経営陣は、現在の市場圧力を考慮し、2026年度通期の売上高見通しを96億8,000万ドル～99億6,000万ドル（実質的な事業成長率2～5%）、調整後EPSを6.85ドル～7.00ドルに修正しました。当社は、ZTSが短期的な逆風をうまく乗り越えれば、その幅広い製品ポートフォリオ、強力な大型新製品候補のパイプライン、そして実績のあるイノベーション能力を主要な競争優位性として、長期的な成長に向けて有利な立場に立てると考えています。
Related Articles
Australia
Vericel Shares Rise After Q1 Net Loss Narrows, Revenue Rises; 2026 Revenue Guidance Lifted
Vericel (VCEL) shares were up 1.3% in Thursday trading after the company posted a narrower net loss and higher revenue for Q1, and raised its full-year revenue guidance.The company reported Thursday Q1 net loss of $0.12 per diluted share, narrowing from a loss of $0.23 a year earlier.Analysts polled by FactSet expected a loss of $0.15.Revenue for the quarter ended March 31 was $68.4 million, up from $52.6 million a year earlier.Analysts surveyed by FactSet expected $63.7 million.The company said it now expects 2026 total revenue to be between $326 million and $336 million, compared with previous guidance of $316 million to $326 million. Analysts polled by FactSet expect $323.4 million.Price: $37.26, Change: $+0.48, Percent Change: +1.31%
$VCEL
Australia
Liquidity Services Fiscal Q2 Adjusted Earnings, Revenue Increase; Shares Fall
Liquidity Services (LQDT) shares were down nearly 2% in Thursday early trading even after the company reported fiscal Q2 adjusted earnings and revenue that increased year on year and beat analysts' estimates.The company reported fiscal Q2 adjusted earnings of $0.35 per diluted share, up from $0.31 a year earlier.Two analysts polled by FactSet expected $0.30.Revenue for the quarter ended March 31 was $120.7 million, up from $116.4 million a year earlier.One analyst surveyed by FactSet expected $52.9 million.The company expects fiscal Q3 adjusted EPS of $0.30 to $0.39. Two analysts polled by FactSet expect $0.37.Price: $35.83, Change: $-1.39, Percent Change: -3.73%
$LQDT
Research
Research Alert: Grainger Q1 Earnings Jump As Margin Recovery Takes Hold
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:GWW delivered strong Q1 results with EPS of $11.65, up 18.2% Y/Y, significantly beating consensus expectations of $10.21. Sales reached $4.7B with 12.2% organic growth, supported by robust underlying demand across both business segments. The standout metric was 110-bp operating margin expansion to 16.7%, which we view as an inflection point from margin pressures that were a factor for much of 2025, driven by aggressive pricing actions to offset tariff-related cost inflation. Management raised full-year 2026 EPS guidance to $44.25-$46.25 from the previous $42.25-$44.75 range following the uptick in business conditions. Margin recovery was broad-based with High-Touch Solutions North America expanding 20 bps to 42.6% and Endless Assortment growing 40 bps while achieving strong 21.9% sales growth from MonotaRO and Zoro performance. Strong cash generation of $739M supported $345M in shareholder returns and a 10% dividend increase.
$GWW